News — The US Food and Drug Administration has approved a flu vaccine to be taken at home.
FluMist is a nasal spray by AstraZencea which has been on the market since 2003 to protect against the respiratory virus. However, the FDA just approved that it can be administered at home.
The company will make the vaccine available through a third-party online pharmacy which will then be prescribed and shipped to your home.
This option, however, will not be available for the start of the flu season.
Faculty experts at the George Washington University are available to offer insight about respiratory season and the new FDA approval. To schedule an interview with an expert, please contact Katelyn Deckelbaum at [email protected].
is an assistant professor of medicine at the GW School of Medicine and Health Sciences.
is the clinical director of the GW Vaccine Research unit and professor of medicine at the GW School of Medicine and Health Sciences.
is an associate professor of global health and an expert in infectious diseases and epidemiology, at the GW Milken Institute School of Public Health.
is an associate professor of medicine and an infectious disease expert at the GW School of Medicine and Health Sciences.
is an assistant professor in the GW School of Nursing.
-GW-
RSS